(44.200.40.97)
Users online: 11426     
Ijournet
Email id
 

Research Journal of Pharmacy and Technology
Year : 2022, Volume : 15, Issue : 12
First page : ( 5517) Last page : ( 5520)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.52711/0974-360X.2022.00931

Evaluation of Oral and Dental complications caused by Cyclophosphamide in patients with breast cancer in the Shahid-Mostafa Hospital, Ilam, 2019

Roozegar Mohammad Ali1, Nourmohammadi Hassan2, Havasian Mohammadreza3, Seidkhani Hossein4, Jamdar Solmaz5,*

1Department of Periodontology, Faculty of Dentistry, Ilam University of Medical Sciences, Ilam, Iran.

2Department of Internal Medicine, Shahid-Mostafa Khomeini hospital, Ilam University of Medical Sciences, Ilam, Iran.

3Student Research of Committee, Alborz University of Medical Sciences, Karaj, Iran.

4Department of Biostatistics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran.

5Faculty of Dentistry, Alborz University of Medical Sciences, Karaj, Iran.

*Corresponding Author E-mail: dr.solmazjamdar@gmail.com

Online Published on 06 March, 2023.

Abstract

Introduction

The use of chemotherapy over many years has attracted the attention of cancer patients for the treatment or prolongation of significant benefits, but unfortunately, in addition to all the advantages it has, there are consequences. Side effects of chemotherapy in the oral-pink area include inflammation, mouth ulcers, increased prevalence of viral, fungal, bacterial and bleeding infections. These side effects cause significant pain, malnutrition, and even, in some cases, a reduction in the amount of chemotherapy used by the treating physician. The aim of this study was to determine the oral and dental complications caused by cyclophosphamide in patients with breast cancer in the Department of Chemotherapy of Shahid Mostafa Hospital, Ilam Province in 2019.

Materials and Method

The present study is an analytical-cross-sectional study performed on patients with breast cancer at Shahid Mostafa Hospital in Ilam in 2019-2020 and a researcher-made questionnaire was used to collect information.

Results

The mean age of patients was 8.81±50.89 and their age range was between 36 and 69 years, and the mean body mass index was 2.56±24.18 and the range was between 29-19. All patients were female. 68.1% of dental patients, 20.3% had no dental caries, and 11.6% had no debar. The results showed that 89.9% of the patients had oral and dental complications with the use of silcophosphamide. 44.9% of patients had mild mucositis, none of them had moderate mucositis, and 55.1% had severe mucositis. Significant relationships were also found between dry mouth and the severity of mucositis. Patients with low- and moderate-grade dry mouth with severe mucositis were reported to be 31.3 and 75 percent, respectively.

Conclusion

In the case of mucositis, the importance of oral hygiene in cancer patients should be emphasized. Although there is no scientific evidence that oral hygiene plays a role in the prevention and treatment of mucositis, most researchers believe that oral hygiene can reduce the duration and severity of mucositis.

Top

Keywords

Oral and Dental Complications, Cyclophosphamide, Breast Cancer, Ilam.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
733,261,581 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.